Sandur Manganese & Iron Ores Ltd reported a strong Q2 FY27, with revenue rising to Rs 1,506 crore and net profit nearly doubling to Rs 261.25 crore. The company also approved a Rs 200 crore investment into its wholly-owned subsidiary, Royal Sandur MedTech, marking a shift toward diversification. Meanwhile, leadership changes include the appointment of mining veteran G.P. Kundargi and the resignation of independent director Dr. Latha Pillai.
Sandur Manganese & Iron Ores Reports Robust Q2 Growth
Q2 FY27 Net Profit: Rs 261.25 crore
Q2 FY27 Revenue: Rs 1,506.13 crore
Reader Takeaway: Strong operational growth pairs with aggressive diversification, though regulatory land compliance remains a key factor to monitor.
What just happened
Sandur Manganese & Iron Ores Ltd has announced strong financial results for the quarter ended September 30, 2026. The company reported a significant increase in consolidated net profit to Rs 261.25 crore, compared to Rs 138.87 crore in the same quarter last year. Revenue from operations also saw a healthy uptick, reaching Rs 1,506.13 crore versus Rs 1,232.34 crore in Q2 FY26.
Why this matters
The jump in profitability highlights stable operations for the mining and metals firm. The board’s approval of a Rs 200 crore capital infusion into Royal Sandur MedTech Private Limited indicates a clear pivot toward diversifying beyond its core commodities business into medical devices. This expansion is supported by the recent incorporation of three new wholly-owned subsidiaries focusing on education, hospitality, and medical technology.
Board and Governance Update
The company has appointed G. P. Kundargi as an Additional Director, effective November 12, 2026. Kundargi is a former Chairman and Managing Director of MOIL Limited and brings deep domain expertise. Simultaneously, independent director Dr. Latha Pillai has resigned, citing personal commitments, effective November 4, 2026.
Risks to watch
The company remains in the middle of a forest lease compliance process. Following a demand notice for Rs 139.05 crore from the Deputy Conservator of Forest, the firm is actively transferring land for compensatory afforestation. While the firm has already registered significant acreage, investors should track the completion of ongoing registrations for the remaining land parcels to ensure full regulatory clearance.
What to track next
The market will likely focus on the execution timeline of the Rs 200 crore MedTech investment and the operational scaling of the newly renamed subsidiaries, Royal Sandur Metals and Royal Sandur Green Steel.